Ep Wealth Advisors, LLC Novartis Ag Transaction History

Ep Wealth Advisors, LLC

$11.3 Billion
Q3 2024

A detailed history of Ep Wealth Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 13,630 shares of NVS stock, worth $1.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,630

Previous 11,793 15.58%

Holding current value

$1.41 Million

Previous $1.26 Million 24.86%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $194,960 - $222,074	1,837 Added 15.58%	13,630 $1.57 Million
Q2 2024 Aug 19, 2024	SELL	$92.57 - $107.37 $121,359 - $140,762	-1,311 Reduced 10.0%	11,793 $1.26 Million
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $195,494 - $222,580	2,052 Added 18.57%	13,104 $1.27 Million
Q4 2023 Feb 28, 2024	SELL	$92.27 - $101.54 $110,354 - $121,441	-1,196 Reduced 9.76%	11,052 $1.12 Million
Q3 2023 Nov 22, 2023	SELL	$94.73 - $105.13 $1.52 Million - $1.68 Million	-16,000 Reduced 56.64%	12,248 $1.25 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $831,569 - $942,931	8,988 Added 46.67%	28,248 $2.85 Million
Q1 2023 Jun 05, 2023	BUY	$80.03 - $92.81 $1.54 Million - $1.79 Million	19,260 New	19,260 $1.77 Million
Q4 2022 Jun 12, 2023	SELL	$75.55 - $92.52 $1.07 Million - $1.31 Million	-14,185 Reduced 73.65%	5,075 $460,000
Q2 2022 Aug 11, 2022	BUY	$80.52 - $93.75 $211,848 - $246,656	2,631 Added 32.21%	10,800 $913,000
Q1 2022 May 20, 2022	SELL	$80.11 - $90.62 $25,234 - $28,545	-315 Reduced 3.71%	8,169 $717,000
Q4 2021 Feb 17, 2022	BUY	$79.7 - $88.13 $32,358 - $35,780	406 Added 5.03%	8,484 $742,000
Q3 2021 Nov 23, 2021	BUY	$81.78 - $95.14 $396,960 - $461,809	4,854 Added 150.56%	8,078 $661,000
Q3 2021 Nov 16, 2021	SELL	$81.78 - $95.14 $332,353 - $386,648	-4,064 Reduced 55.76%	3,224 $661,000
Q2 2021 Aug 24, 2021	BUY	$85.24 - $94.15 $70,408 - $77,767	826 Added 12.78%	7,288 $665,000
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $2,839 - $3,347	34 Added 0.53%	6,462 $552,000
Q4 2020 Feb 18, 2021	SELL	$78.07 - $94.43 $81,427 - $98,490	-1,043 Reduced 13.96%	6,428 $607,000
Q3 2020 Nov 17, 2020	BUY	$82.14 - $91.0 $75,650 - $83,811	921 Added 14.06%	7,471 $650,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $113,221 - $127,448	-1,399 Reduced 17.6%	6,550 $572,000
Q1 2020 May 18, 2020	BUY	$70.67 - $99.01 $14,275 - $20,000	202 Added 2.61%	7,949 $655,000
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $16,110 - $18,215	-191 Reduced 2.41%	7,747 $734,000
Q3 2019 Nov 18, 2019	BUY	$85.54 - $94.26 $163,552 - $180,225	1,912 Added 31.73%	7,938 $690,000
Q2 2019 Aug 27, 2019	BUY	$75.4 - $92.8 $270,535 - $332,966	3,588 Added 147.17%	6,026 $550,000
Q1 2019 May 20, 2019	BUY	$75.32 - $86.15 $1,732 - $1,981	23 Added 0.95%	2,438 $234,000
Q4 2018 Feb 19, 2019	BUY	$73.66 - $82.02 $177,888 - $198,078	2,415 New	2,415 $207,000

Others Institutions Holding NVS

# of Institutions

1,425

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ep Wealth Advisors, LLC with notifications on news.

Account

Ep Wealth Advisors, LLC Novartis Ag Transaction History